Drug recall · October 31, 2018
Meropenem for Injection recall
Why: Lack of assurance of sterility: loss of container integrity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Meropenem for Injection, USA (I.V.), 1 gram/vial, 25 vials per carton, Sterile, Rx Only, Manufactured for: Hospira, Inc., Lake Forest, IL 60045, USA. NDC carton: 0409-3506-01; NDC vial: 0409-3506-11
- Lots / codes
Lot: 609G047, EXP 10/2018
- Quantity
- 71,075 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the US and Puerto Rico
- Initiated
- September 20, 2018 · Voluntary: Firm initiated
- Classified
- October 24, 2018
- Reported
- October 31, 2018
- Ended
- September 17, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meropenem
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.